DSP Nifty Healthcare Index Fund
Direct · Growth ₹11.05
18 Jun 2026
NAV
—
Sharpe
-8.4%
Max Drawdown
?
Max Drawdown
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
The largest peak-to-trough decline in the fund's NAV. Shows the worst-case loss an investor would have experienced at any point in the fund's history.
NA
TER
If you invested ₹1,00,000 every month via SIP, here's how this fund has historically performed across different time horizons.
| Duration | Invested | Median Value | XIRR | Min XIRR | Max XIRR |
|---|---|---|---|---|---|
| 1 Year | ₹12.00 L | ₹12.66 L | 13.0% | 8.5% | 19.3% |
SIP returns vs benchmark & category
Annualised SIP return (XIRR) over each rolling horizon — like-for-like, not lump-sum.
| Duration | Fund SIP XIRR | NIFTY 50 | Category avg | Fund edge |
|---|---|---|---|---|
| 1 Year | 13.0% | 14.5% | 9.1% | -1.5% |
Not enough data to compute rolling returns.
-8.4%
Max Drawdown
6 mo
Drawdown Duration
1 mo
Recovery Time
-2.7%
Avg Drawdown
Compared against NIFTY 50
| Duration | Alpha | Beta | Upside Capture | Downside Capture | Fund CAGR | Bench CAGR |
|---|---|---|---|---|---|---|
| 1 Year | +9.40 | 0.63 | 75.0% | 58.5% | 9.6% | -3.5% |
| 3 Years | +1.43 | 0.63 | 75.0% | 58.5% | 3.1% | -1.2% |
| 5 Years | -0.12 | 0.63 | 75.0% | 58.5% | 1.9% | -0.7% |
| 7 Years | -0.78 | 0.63 | 75.0% | 58.5% | 1.3% | -0.5% |
| 10 Years | -1.28 | 0.63 | 75.0% | 58.5% | 0.9% | -0.4% |
| 12 Years | -1.47 | 0.63 | 75.0% | 58.5% | 0.8% | -0.3% |
| 15 Years | -1.66 | 0.63 | 75.0% | 58.5% | 0.6% | -0.2% |
19
Total Holdings
76.2%
Top 10 Weight
2
Sectors
| # | Stock | % of NAV |
|---|---|---|
| 1 | Sun Pharmaceutical Industries Limited | 19.29% |
| 2 | Dr. Reddy's Laboratories Limited | 7.93% |
| 3 | Apollo Hospitals Enterprise Limited | 7.91% |
| 4 | Divi's Laboratories Limited | 7.83% |
| 5 | Max Healthcare Institute Limited | 7.42% |
| 6 | Cipla Limited | 7.14% |
| 7 | Lupin Limited | 5.82% |
| 8 | Torrent Pharmaceuticals Limited | 4.57% |
| 9 | Fortis Healthcare Limited | 4.29% |
| 10 | Laurus Labs Limited | 4.00% |